Pancreatic Cancer Research

ResearcherHellenic Society of Medical OncologyActive in the last 2 years

George Papaxoinis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6900-784X; OpenAlex author ID A5070188844. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. Phase Ib-II study of ramucirumab combined with nab-paclitaxel and Gemcitabine as first-line treatment in patients with advanced pancreatic adenocarcinoma (RACI… Co-author DOI 10.1016/j.ctarc.2026.101481↗
  2. Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemothera… First author DOI 10.1080/0284186x.2022.2053198↗
  3. Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.3390/cancers13020198↗
  4. Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece. Co-author DOI 10.1155/2020/5304516↗
  5. Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer. Co-author DOI 10.21873/anticanres.11232↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. George Fountzilas · 3 shared papers, 2016–2026 · strength 0.39
  2. Elena Fountzilas · 2 shared papers, 2021–2026 · strength 0.34
  3. George E. Pentheroudakis · 2 shared papers, 2016–2026 · strength 0.30
  4. Ioannis Kotsantis · 1 shared paper, 2026 · strength 0.25
  5. Georgios Oikonomopoulos · 2 shared papers, 2020–2021 · strength 0.17
  6. Christos Dervenis · 2 shared papers, 2016–2021 · strength 0.14
  7. Dimitrios G. Pectasides · 2 shared papers, 2016–2021 · strength 0.14
  8. Alan Anthoney · 1 shared paper, 2022 · strength 0.13
  9. Ángela Lamarca · 1 shared paper, 2022 · strength 0.13
  10. Rille Pihlak · 1 shared paper, 2022 · strength 0.13
  11. Konstantinos Vellios Kamposioras · 1 shared paper, 2022 · strength 0.13
  12. Richard A Hubner · 1 shared paper, 2022 · strength 0.13
  13. Juan W. Valle · 1 shared paper, 2022 · strength 0.13
  14. Mairead Geraldine McNamara · 1 shared paper, 2022 · strength 0.13
  15. George Zarkavelis · 1 shared paper, 2021 · strength 0.09
  16. Nikolaos K. Kentepozidis · 1 shared paper, 2021 · strength 0.09
  17. Philippos C. Patsalis · 1 shared paper, 2021 · strength 0.09
  18. Nikolaos Xenidis · 1 shared paper, 2020 · strength 0.08
  19. Davide N. Mauri · 1 shared paper, 2020 · strength 0.08
  20. Ioannis Boukovinas · 1 shared paper, 2020 · strength 0.08
  21. Christos Agalianos · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.